Article
29 Nov 2024
Fenwick Securities Law Update—November 25, 2024
AUTHORS CONTENT
Article
18 Oct 2023
SEC Adopts Rules For Shorter Deadlines And More Transparency In Share Ownership Reporting
Article
01 Apr 2022
Fenwick's Going Public Report: IPOs, SPACs And Direct Listings Facing Headwinds In 2022 After Record Year
Article
23 Dec 2021
SEC Proposed Rules Would Revise Rule 10b5-1 Requirements And Require Enhanced Disclosure Of 10b5-1 Plans And Share Buybacks
Article
06 Sep 2021
Fenwick's Going Public Report: First Half 2021
Article
03 Mar 2021
IPO Landscape: Surging SPACs And A Pandemic Boom Ahead
Article
09 Dec 2020
SEC Issues Final Rules Amending MD&A Requirements And Other Financial Disclosures
Article
16 Nov 2020
SEC Adopts Amendments Facilitating Opportunities For Access To Additional Capital
Article
30 Sep 2020
SEC Updates Rule 14a-8 Shareholder Proposal Rules
Article
02 Sep 2020
Technology And Life Sciences IPO Survey – First Half 2020
Article
02 Sep 2020
SEC Expands "Accredited Investor" Definition And Modernizes Disclosure Required By Regulation S-K
Article
29 Jun 2020
SEC Emphasizes Continued Importance Of Financial Disclosures In Light Of COVID-19
Article
09 Jun 2020
SEC Streamlines Disclosure Requirements For Acquired And Disposed Businesses
Article
25 May 2020
National Stock Exchanges Provide Relief In Light Of COVID-19
Article
05 May 2020
SEC Urges Current And Forward-Looking Disclosure On COVID-19 Impacts
Article
05 May 2020
COVID-19: Employment, Securities And Tax Considerations For Life Sciences Companies
Article
13 Apr 2020
SEC Provides Disclosure Guidelines And Further Extends Filing Deadlines For Public Companies Affected By COVID-19
Article
03 Apr 2020
COVID-19: Key Securities Law Impacts And Considerations For Public Life Sciences Companies (Video)
Article
10 Mar 2020
SEC Provides Extension Of Filing Deadlines For Companies Affected By Coronavirus
Article
20 Feb 2020
January 2020 SEC Updates: New Guidance On Use Of Financial Metrics, Significant Proposed Changes To MD&A And More